chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PCR test 18Jan Positive; PCR test 18Jan Positive; + sick 16Jan ST rhinorrhea with neg AG test; + sick 16Jan ST rhinorrhea with neg AG test; high fevers 101; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP) from product quality group.  A 27 year-old female patient received bnt162b2 (BNT162B2), administration date 03May2021 (Lot number: ER8729) at the age of 26 years as dose 2, single and administration date 12Apr2021 (Lot number: EW0172) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 18Jan2022, outcome "recovering" and all described as "PCR test 18Jan Positive"; ILLNESS (non-serious), RHINORRHOEA (non-serious) all with onset 16Jan2022, outcome "recovering" and all described as "+ sick 16Jan ST rhinorrhea with neg AG test"; PYREXIA (non-serious) with onset 16Jan2022, outcome "recovering", described as "high fevers 101". The events "pcr test 18jan positive", "pcr test 18jan positive", "+ sick 16jan st rhinorrhea with neg ag test", "+ sick 16jan st rhinorrhea with neg ag test" and "high fevers 101" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: body temperature: (16Jan2022) 101, notes: high fevers; sars-cov-2 test: (16Jan2022) negative, notes: Other; (18Jan2022) positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19, illness, rhinorrhoea, pyrexia.  It was unknown that patient receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown that the patient was diagnosed with COVID-19, prior to vaccination. The most recent COVID-19 vaccine was administered was withheld facility. The patient had been tested for COVID-19 since the vaccination. Adverse event result in doctor or other healthcare professional office/clinic visit.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine cannot be excluded for the reported events of COVID- and Vaccination failure
Experienced ?COVID arm? with hard, red splotchy spot on the injection site over a week after first dose
pt recv vax 22JUL95 & 6NOV95 pt devel a rash on forehead;pt presented to MD 13NOV95 w/a vesicular rash over the rt bridge of nose,rt eyebrow,rt forehead w/extension into the hairline & rt parietal area;dx w/varicella zoster
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
10025197:LYMPHADENOPATHY; Narrative:  Other Relevant HX: Other; Lymphadenopathy
Information has been received from a medical assistant concerning a newborn female who's mother was vaccinated on 21-MAY-2009 and 29-JUL-2009 with a 0.5 ml first and a second dose (lot # 662300/0100Y) of GARDASIL. During pregnancy the patient was also exposed to YASMIN, CONCEPT and iron (unspecified) ("INTERJCA"). The patient experienced pericardial effusion, intracranial ventriculomegaly, stomach duodenum, possibly aneuploidy and alpha thalassemia trait (after baby born no abnormalities). The patient's outcome was unknown. The mother's experience has been captured in WAES # 0909USA01458. Pericardial effusion, intracranial ventriculomegaly, possibly aneuploidy and alpha thalassemia trait were considered to be congenital anomalies. Additional information has been requested.
Excessive crying, followed by two episodes of loss of consciousness, and not breathing. 5/19/08-records received for DOS 6/1/07-Presented to ED after fussy screaming after awakening from nap. Inconsolable. Pale, eyes not making eye contact, tone limp. Did not respond to stimuli. Fifteen minutes before returned to baseline. No fever.  Impression: Apneic spells.
General weakness, fatigue, subjective low grade fever, brief headache and cold sores upper lip. Began one day after vaccination; improving within one weak. Treated with Tylenol.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received SHINGRIX for prophylaxis. On 3rd May 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 3rd May 2018, less than a day after receiving SHINGRIX, the patient experienced pain in arm. On 4th May 2018, the patient experienced influenza-like symptoms. On 5th May 2018, the outcome of the influenza-like symptoms was recovered/resolved. On an unknown date, the outcome of the pain in arm was recovered/resolved. The reporter considered the pain in arm to be related to SHINGRIX. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided a follows: The reporter reported the case for herself. The patient received SHINGRIX in the left arm and experienced pain in her arm. The pain resolved in a couple of days. The day after receiving the vaccine, the patient experienced flu-like symptoms that resolved in 1 day. The patient had denied permission to contact their physician. This case was linked US2018186332, reported by the same reporter.
This spontaneous report was received from a consumer refers to himself as 84 year old male patient. The patient pertinent medical history included he was very active his whole life. On an unknown date in October 2011, the patient was vaccinated with ZOSTAVAX standard dose. Concomitant medication included MINOCYCLINE. On an unknown date in the year 2011 (also reported that 2 to 3 weeks after vaccination), the patient experienced water bubbles on his left leg below the knee. The water bubbles appeared intermittently and leave a scab when they disappear and often times reappear in the same location. The patient treated the water bubbles with a hot salt bath. On an unknown date in January 2012, the patient had the water bubbles biopsied and the patient was told that they were related to an unspecified issue with his immune system. On an unknown date, the patient developed rash and he was not sure about the dates and severity related to that symptom. On an unknown date, the patient felt tired and has no ambition to be active anymore after having the vaccine. The patient was treated with prednisone since on an unknown date in April 2013. The outcome of the events was reported as not recovered. The physician did not provide any causality between the events and the suspect product. Additional information has been requested.
With each succeeding rabies vaccination had increase symptoms of malaise, fatigue, backache, and some diarrhea. Dose # 3 had extreme fatigue, soreness of back and other muscles. no joint redness/swelling or at injection site.
Patient developed an itchy rash and 3 large welts on back 2 days after receiving ZOSTAVAX.
her tongue went numb; tingling on her tongue; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient previously took flu shot for immunization and experienced achy in that arm.  The patient experienced her tongue went numb and tingling on her tongue on 28Dec2020 with outcome of recovered. After the first part she took 28Dec2020 and she had like a quick reaction, it was a tingling on her tongue and then her tongue went numb, she took diphenhydramine hydrochloride (BENADRYL) and then she was fine.   Information about Lot/Batch has been requested.
I was 24 weeks pregnant when I had my baby boy .he was born 1lb and 6 oz . He was born August 1 2022 and my due date was November 20 2022
Second dose of Shingrix - Fever, chills, aches & pains, headache, fatigue, everything hurt.  Injection site swelling
patient first received Pfizer at another pharmacy and then came in to our pharmacy 2 weeks later and got the second shot- but was given moderna by mistake. Patient was feeling under the weather for a few days but is now feeling better
This spontaneous report was received from a Registered Nurse and refers to multiple unspecified patients of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, since approximately 2011 (reported as "over the past 6 years"), the patients were vaccinated with doses of VARIVAX (doses, routes of administration, lot numbers and expiration dates were not provided) reconstituted with sterile diluent (manufacturer unknown)(doses, routes of administration, lot numbers and expiration dates were not provided). On unknown dates, the patients experienced injection site stinging. Product quality complained was not involved. The outcome of the event was unknown. Causality assessment was not specified. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA014280: US-009507513-1705USA014282: US-009507513-1705USA008994:
Tiredness  (February 10, 2021--Late Afternoon) Injection site pain (February 10, 2021--Late Afternoon) Headaches (February 10, 2021-Evening) Slight pain upon breathing in upper chest near throat(February 11, 2021 Afternoon-through the night)-Acetaminophen Headache (February 11, 2021--Most of the day)-Tylenol Pain in left upper shoulder (February 11, 2021-All day) Beginning of skin irritation (February 12, 2021)  Full eruption of hives on torso, thighs--outer- arms (February 13, 2021) Arm pain and thigh pain upon pressing (lymph nodes) (February 13-15, 2021) Pain in breast (lymph nodes (February 13-15, 2021)
Severe headache (unable to perform daily activities). Increase in heart PVC and outer ear infection.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided. Reporter stated that no adverse reactions were reported by any patients.
10 days p/vax pt was seen for gen rash, irritability, & dec appetite & low grade temp;
Increased BP; 10 days after shot had neck pain; Teeth & jaw hurt; Cough; jaw hurt; Congestion; 10 days after shot had muscle pain; 10 days after shot had joint pain; Headache; Same day of shot sore arm & achy.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 09:00 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. The patient medical history included neuropathy, very frequent premature ventricular contractions (PVC's), severe arthritis, high blood pressure, degenerative disc disease and bulging discs. The patient had a history of drug allergy to codeine, steroids, ultram, augmentin, cipro, doxycycline and sulphur antibiotics. The concomitant medications included SYNTHROID, diltiazem (MANUFACTURER UNKNOWN), flecainide (MANUFACTURER UNKNOWN), calcitriol (MANUFACTURER UNKNOWN) and ibup(ibuprofen) (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 10Mar2021, (same day of shot) the patient experienced sore arm and achy. The patient felt better after 2 days, but 10 days after the shot on 19Mar2021at 22:00, the patient experienced muscle, neck, joint pain, headache, teeth and jaw hurt, cough, congestion and increased blood pressure (BP). No therapeutic measures were taken as a result of adverse events. The clinical outcome of the event pain in arm was recovering and the clinical outcome of the events muscle pain, neck pain, joint pain, headache, toothache and jaw pain, cough, congestion nasal, blood pressure increased was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Period cramps and flow got much worse after vaccine.; Period cramps and flow got much worse after vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 16:45 (Batch/Lot number: unknown) at the age of 23 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID" (unspecified if ongoing), notes: if Covid prior vaccination: YES. There were no concomitant medications. The following information was reported: DYSMENORRHOEA (non-serious), MENSTRUAL DISORDER (non-serious) all with onset 18May2021, outcome "recovered with sequelae" (2021) and all described as "Period cramps and flow got much worse after vaccine.". Therapeutic measures were not taken as a result of dysmenorrhoea, menstrual disorder.  Additional information: No known allergies. No other vaccine in four weeks. No Other medications in two weeks. Patient was not pregnant at the time of vaccination. Patient recovered with lasting effects. No Covid tested post vaccination. Received BNT162B2 (Lot number: Not reported), administered in arm left on 24Mar2021 as dose 2, single for covid-19 immunisation. Facility type vaccine: Other.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Patient received seasonal flu and pneumonia immunization in left arm by request - arm became swollen, red, inflamed and warm - saw MD and was diagnosed w/ cellulitis - received a course of levofloxacin and recovered w/ no additional therapy.
This spontaneous report was received from a healthcare worker refers to a 4 month old patient of unknown demography. On 18-JUN-2014, the patient was vaccinated with expired dose of ROTATEQ (dose and frequency were not reported) orally. No adverse effects reported. No AE/PQC. Additional information is not expected.
Grossly bloody stools with mucus for 14-15 hours prior to seeing in office. Did not have stool 07/26 am. No vomiting. Urinating normally. Slept normally.
swelling on her arm; administrated with a 3rd dose of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of swelling arm in a 100-year-old female patient who received Herpes zoster (Shingrix) (batch number xm22g, expiry date 31st August 2023) for prophylaxis.   Previously administered products included Shingrix (On an unknown date, patient received first does of Shingrix) and Shingrix (On an unknown date, patient received second does of Shingrix).   On 1st June 2022, the patient received the 3rd dose of Shingrix. On 1st June 2022, unknown after receiving Shingrix, the patient experienced extra dose administered. On 2nd June 2022, the patient experienced swelling arm. On 2nd June 2022, the outcome of the swelling arm was not recovered/not resolved. On an unknown date, the outcome of the extra dose administered was unknown.   It was unknown if the reporter considered the swelling arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 2-Jun-2022 Reporter's Comments: The patient received a dose of Shingrix and experienced swelling in arm and extra dose administered. On 2nd June 2022, 1 day after receiving Shingrix, the patient experienced swelling arm. The reporter consented to follow up. Additional Supportive Information: The patient received third dose of Shingrix which led to extra dose administered. The information of first and second dose was not provided.
Tinnitus started 1-2 days after 1st Pfizer COVID vaccine.  Have it in both ears.  Has been 3+ weeks since 1st shot and tinnitus has not gotten better.  I would rate the tinnitus as "moderate".  It is definitely noticeable, high-pitched ringing in both ears.  Not debilitating but definitely present.  I am scheduled for my second shot next week but will likely not get it, for fear of making the tinnitus worse than it already is.  I can barely put up with it now, if it gets any worse after the 2nd dose I will greatly regret getting the 2nd dose, so I am likely to skip it.
swollen; painful stiff neck; painful stiff neck; swollen, tender, sore arm pits; swollen, tender, sore arm pits; swollen, tender, sore arm pits; chills; soaking wet; fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administration date 03Oct2021 (Batch/Lot number: unknown) at the age of 55 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 Immunization, reaction(s): "he was diagnosed with Covid-19 infection three weeks after receiving his first dose/contracted the Covid virus", "he was diagnosed with Covid-19 infection three weeks after receiving his first dose/contracted the Covid virus", "sick for a month", "high fevers coming and going". The following information was reported: PYREXIA (non-serious) with onset 04Oct2021, outcome "unknown", described as "fever"; SWELLING (non-serious) with onset 05Oct2021, outcome "unknown", described as "swollen"; MUSCULOSKELETAL STIFFNESS (non-serious), NECK PAIN (non-serious) all with onset 05Oct2021, outcome "unknown" and all described as "painful stiff neck"; LYMPHADENOPATHY (non-serious), TENDERNESS (non-serious), AXILLARY PAIN (non-serious) all with onset 05Oct2021, outcome "unknown" and all described as "swollen, tender, sore arm pits"; CHILLS (non-serious) with onset 05Oct2021, outcome "unknown", described as "chills"; HYPERHIDROSIS (non-serious) with onset 04Oct2021, outcome "unknown", described as "soaking wet". The patient underwent the following laboratory tests and procedures: body temperature: (unspecified date) 102; (unspecified date) 100.1; (04Oct2021) 100.2.  Additional information: Patient was looking for insights as he had no health issues. He also states that he was in great health and had never had this experience. His pain had subsided in his neck, but under his arms was still store.  Follow-up (11Nov2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Patient was given the incorrect vaccine. After administration during a flu shot clinic at a place of business, the patient asked if she received the Pfizer Covid vaccine and indicated she had signed up to receive that and not the flu shot.
Day 9 after injection noticed small suspicious bruises.  Day 10 slight vaginal bleeding assumed was UTI called for prescription was given Bactrim.  Day 12 large contusion on back,  right breast, left hand and left foot.  Went to emergency per doctors request.  Diagnosed with ITP and confirmed UTIPlatelet level was severely low (18,000) .  Changed antibiotic from Bactrim to Kefflex and was given 60mg of Prednisone.  Increased platelets to 68000.  Reduced Steroid to 20mg. due to progress. Continued to increase platelets.  Stopped steroid and continued to see increase in platelet production.  Today levels are 148,000.  Did not take second scheduled vaccine.
Initial report received from a health care professional on 16 November 2011. A female patient received an injection (route and site not reported) of ADACEL, sanofi pasteur Ltd. lot number not reported, on an unknown date. The patient's medical history and concomitant medications were not reported. On an unknown date and immediately after the vaccine, the patient developed shortness of breath, lightheadedness and pounding of the heart which persisted. The patient was seen by a physician. The outcome was reported as not recovered. Documents held by sender: None.
I developed a high fever of 102.1, body aches, swollen lymph nodes in my under arm. I developed post-nasal drip and have not recovered from it. I saw medical care because I was continuing to feel dizzy, weak, exhausted, had sinus pressure and pain. I believed that I had a sinus infection that would not go away. I have developed mono. I have not had close physical contact with anybody since April.  I have not shared eating utensils, cups or kissed anyone since April. I live alone and have not had take out food since September. The provider I saw said somebody else who had gotten their vaccine booster also developed mono. It seems like the vaccine reactivated the Epstein-Barr virus.
Subsequent menses (date above is approximate) lasted 10 days instead of their usual 3-5.
body aches and sore arm. body aches started up on the 6th of January. Headache as well and a cough.